Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Sweet

Showing results (121-130 of 142) with videos related to

Pageof 15
Sort By:
Journal of Medicinal Chemistry|January 1, 1980
Heterocyclic analogues of the antihypertensive beta-adrenergic blocking agent (S)-2-[3-(ter-butylamino)-2-hydroxypropoxy]-3-cyanopyridineJ J Baldwin, E L Engelhardt, R Hirschmann, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1979
Diuretic and antihypertensive effects of 2-aminoethyl-4-(1,1-dimethylethyl)-6-iodophenol hydrochloride (MK-447)A Scriabine, L S Watson, H F Russo, et al.
Journal of Medicinal Chemistry|June 1, 1984
3-Hydroxy-alpha-methyltyrosine progenitors: synthesis and evaluation of some (2-oxo-1,3-dioxol-4-yl)methyl estersW S Saari, W Halczenko, D W Cochran, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1981
Antihypertensive activity of N-[(S)-1-(ethoxycarbonyl)-3-phenylpropyl]-L-Ala-L-Pro (MK-421), an orally active converting enzyme inhibitorC S Sweet, D M Gross, P T Arbegast, et al.
Journal of Medicinal Chemistry|April 1, 1983
2-(Aminomethyl)phenols, a new class of saluretic agents. 6. Effects of N,O-spiroannulation and subsequent quaternizationG E Stokker, E M Schultz, R L Smith, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|January 21, 2011
PSD-95 alters microtubule dynamics via an association with EB3Eric S Sweet, Michelle L Previtera, Jose R Fernández, et al.
Journal of Medicinal Chemistry|November 1, 1979
Symbiotic approach to drug design: antihypertensive beta-adrenergic blocking agentsJ J Baldwin, W C Lumma, G F Lundell, et al.
Clinical Science and Molecular Medicine. Supplement|December 1, 1978
Antihypertensive activity of metyrosine in spontaneously hypertensive rats and its enhancement by carbidopaA Scriabine, C T Ludden, C S Sweet, et al.
Journal of Medicinal Chemistry|June 1, 1979
beta-Adrenergic blocking agents with acute antihypertensive activityJ J Baldwin, E L Engelhardt, R Hirschmann, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1992
In vivo pharmacology of L-158,809, a new highly potent and selective nonpeptide angiotensin II receptor antagonistP K Siegl, R S Chang, N B Mantlo, et al.
Pageof 15

Showing results (121-130 of 142) with videos related to

Sort By:
Pageof 15
Journal of Medicinal Chemistry|January 1, 1980
Heterocyclic analogues of the antihypertensive beta-adrenergic blocking agent (S)-2-[3-(ter-butylamino)-2-hydroxypropoxy]-3-cyanopyridineJ J Baldwin, E L Engelhardt, R Hirschmann, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1979
Diuretic and antihypertensive effects of 2-aminoethyl-4-(1,1-dimethylethyl)-6-iodophenol hydrochloride (MK-447)A Scriabine, L S Watson, H F Russo, et al.
Journal of Medicinal Chemistry|June 1, 1984
3-Hydroxy-alpha-methyltyrosine progenitors: synthesis and evaluation of some (2-oxo-1,3-dioxol-4-yl)methyl estersW S Saari, W Halczenko, D W Cochran, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1981
Antihypertensive activity of N-[(S)-1-(ethoxycarbonyl)-3-phenylpropyl]-L-Ala-L-Pro (MK-421), an orally active converting enzyme inhibitorC S Sweet, D M Gross, P T Arbegast, et al.
Journal of Medicinal Chemistry|April 1, 1983
2-(Aminomethyl)phenols, a new class of saluretic agents. 6. Effects of N,O-spiroannulation and subsequent quaternizationG E Stokker, E M Schultz, R L Smith, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|January 21, 2011
PSD-95 alters microtubule dynamics via an association with EB3Eric S Sweet, Michelle L Previtera, Jose R Fernández, et al.
Journal of Medicinal Chemistry|November 1, 1979
Symbiotic approach to drug design: antihypertensive beta-adrenergic blocking agentsJ J Baldwin, W C Lumma, G F Lundell, et al.
Clinical Science and Molecular Medicine. Supplement|December 1, 1978
Antihypertensive activity of metyrosine in spontaneously hypertensive rats and its enhancement by carbidopaA Scriabine, C T Ludden, C S Sweet, et al.
Journal of Medicinal Chemistry|June 1, 1979
beta-Adrenergic blocking agents with acute antihypertensive activityJ J Baldwin, E L Engelhardt, R Hirschmann, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1992
In vivo pharmacology of L-158,809, a new highly potent and selective nonpeptide angiotensin II receptor antagonistP K Siegl, R S Chang, N B Mantlo, et al.
Pageof 15